# Joost Holthuis

> Joost Holthuis is a startup investor at BioGeneration Ventures (The Hague). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioGeneration Ventures](https://shizune.co/investors/profile/biogeneration-ventures)
- Location: The Hague, The Netherlands
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/joost-j-m-holthuis/2/9/272

Joost Holthuis is a startup investor at BioGeneration Ventures in The Hague. Joost is founder and former CEO of Octoplus N.V. and has an extensive experience in biotech and pharma. Joost currently serves on the board of Medisse and is executive director corporate development of Cristal Therapeutics.From 1988-1994 Joost worked for Chiron as head of the analytical and product development laboratories. He was CEO ofOctoPlus N.V. from 1995 till 2009. In his time at OctoPlus he raised in excess of € 47 million of venture capital financing and successfully led the company through its IPO. During this period he was responsible for the growth of the company to 150 FTE’s and the realization of multiproduct facilities of over 5000 square meters, He also was responsible for the growth of the service business to > €15 M in 2008 and an > € 100 M out licensing deal. In addition to his role as Venture Partner in BioGeneration Ventures he is an independent entrepreneur in the Life Sciences and active in boards of various organizations in the industry, advisory panels for the Dutch government and a board member in 2 early stage companies.Joost Holthuis is a pharmacist by training and holds a PhD from the University of Utrecht.

## About BioGeneration Ventures

VC Fund · Naarden, The Netherlands

BioGeneration Ventures is investing in the next generation of Life Sciences companies in the Netherlands. BioGeneration Ventures invests in Dutch start-up and early stage life sciences companies. The BioGeneration Ventures team is specialized in the evaluation and management of early stage companies. Their involvement goes beyond thefinancial investment. They work closely with scientists, academic institutions, entrepreneurs and industry experts to accelerate the development and to optimize the commercial potential of their portfolio company's technologies. BioGeneration Ventures began operating in 2006 and the fund is backed by the Netherlands Genomics Initiative (NGI) and the Netherlands Organisation for Scientific Research (NWO) in combination with the holding company of Leiden University and ABN-AMRO Capital as lead private investors.

5 contacts available at BioGeneration Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Daniela Couto | General Partner | https://shizune.co/investors/profile/daniela-couto |
| Edward van Wezel | Founder and Managing Partner | https://shizune.co/investors/profile/edward-van-wezel |
| Joost Holthuis | Venture Partner | https://shizune.co/investors/profile/joost-holthuis |
| Oskar Slotboom | Managing Partner | https://shizune.co/investors/profile/oskar-slotboom |
| Elena Ritsou | Venture Partner | https://shizune.co/investors/profile/elena-ritsou |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co